Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women

Correlation between serum carnitine level and Soluble Receptors for Advance Glycation End Products(sRAGE) in Clomiphene Citrate Resistant- PCOS Women

The most frequently diagnosed condition in women at the age of reproduction is the polycystic ovarian syndrome (PCOS).it could be related to a complex endocrine condition, due to its heterogeneity and uncertainty about its etiology, as the clinical highlights of PCOS incorporate those related to rep...

Full description

Bibliographic Details
Main Authors:	Nabigh A NAJI, Shatha H Ali, Fatin S. Farhan
Format:	Article
Language:	English
Published:	College of Pharmacy University of Baghdad 2021-06-01
Series:	Iraqi Journal of Pharmaceutical Sciences
Subjects:	poly cystic ovarian syndrome, soluble receptor of advance glycation end products (srage) , serumtotal carnitine .
Online Access:	https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1190

Similar Items

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Is a Sensitive Biomarker in Human Pulmonary Arterial Hypertension
by: Franziska Diekmann, et al.
Published: (2021-08-01)

The impact of polytrauma on sRAGE levels: evidence and statistical analysis of temporal variations
by: Lukas L. Negrin, et al.
Published: (2019-03-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a
by: Mahnoosh Rahimi, et al.
Published: (2018-03-01)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
by: Rui Wu, et al.
Published: (2020-10-01)

sRAGE is associated with low waist circumference and Hb levels in NAFLD
by: Hyogo Hideyuki, et al.
Published: (2013-12-01)

Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)
by: Sherif W. Mansour, et al.
Published: (2021-10-01)

Differential Effects of Dry vs. Wet Heating of β-Lactoglobulin on Formation of sRAGE Binding Ligands and sIgE Epitope Recognition
by: Hannah E. Zenker, et al.
Published: (2019-06-01)

Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
by: Deepika Garg, et al.
Published: (2015-12-01)

Soluble receptor for advanced glycation end products (sRAGE) and carotid intima-media thickness (CIMT) in type 1 diabetes Mellitus: Possible association with diabetic vascular complications
by: Eman M. Sherif, et al.
Published: (2014-10-01)

The cardiovascular complications of diabetes: a striking link through protein glycation
by: Ahmad Mousa Numan, et al.
Published: (2020-12-01)

Regulatory Functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS Mouse Model: Focus on Antioxidant/Antiglycative Molecular Pathways in the Ovarian Microenvironment
by: Giovanna Di Emidio, et al.
Published: (2020-09-01)

S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study
by: Philippe Joly, et al.
Published: (2017-11-01)

Systemic lupus erythematosus and glycation proces
by: Agnieszka Nowak, et al.
Published: (2020-04-01)

Decreased level of serum carnitine might lead to arteriosclerosis progression via the accumulation of advanced glycation end products in maintenance hemodialysis patients
by: Yumi Kamada, et al.
Published: (2017-12-01)

sRAGE and early signs of cardiac target organ damage in mild hypertensives
by: Andrea Maria Maresca, et al.
Published: (2019-02-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

Selected Atherosclerosis-Related Diseases May Differentially Affect the Relationship between Plasma Advanced Glycation End Products, Receptor sRAGE, and Uric Acid
by: Bogna Gryszczyńska, et al.
Published: (2020-05-01)

Differential Regulation of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGEs) and Its Ligands S100A8/A9 Four Weeks Post an Exercise Intervention in a Cohort of Young Army Recruits
by: Ioannis-Alexandros Drosatos, et al.
Published: (2021-09-01)

Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2019-03-01)

Value of RAGE as a circulating biomarker : from sRAGE to anti-sRAGE autoantibodies
by: Lorenzi, Rodrigo
Published: (2013)

Binding of CML-Modified as Well as Heat-Glycated β-lactoglobulin to Receptors for AGEs is Determined by Charge and Hydrophobicity
by: Hannah E. Zenker, et al.
Published: (2020-06-01)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
by: Adel M. A. Assiri, et al.
Published: (2018-05-01)

Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-06-01)

Comparative evaluation of Salivary-Soluble Receptor for Advanced Glycation End Product (sRAGE) levels among betel chewers and chronic periodontitis patients
by: Rajkumar Chandini, et al.
Published: (2021-01-01)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
by: Elena Dozio, et al.
Published: (2020-12-01)

Corrigendum: Obesity and Comorbidity: Could Simultaneous Targeting of esRAGE and sRAGE Be the Panacea?
by: Chinedum Eleazu, et al.
Published: (2019-08-01)

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
by: Amelia K. Fotheringham, et al.
Published: (2020-09-01)

The Effect of ERK Signaling Pathway on the Level of Soluble RAGE (sRAGE) Peptide in AGE-Induced Oxidative Stress
by: Farnosh Shemirani, et al.
Published: (2017-05-01)

The Relationship between the Soluble Receptor for Advanced Glycation End Products and Oxidative Stress in Patients with Palmoplantar Warts
by: Cristina Iulia Mitran, et al.
Published: (2019-10-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study
by: Eva O. Melin, et al.
Published: (2020-10-01)

P.39 The Role of Advanced Glycation End Products in Vascular Ageing. Which Parameter is the Most Suitable as Biomarker?
by: Otto Mayer, et al.
Published: (2020-12-01)

Efek Kortikosteroid Dosis Rendah terhadap Kadar Soluble Receptor for Advanced Glycation End Products Mencit Balb/C Model Sepsis
by: Diding Heri Prasetyo, et al.
Published: (2015-03-01)

A Soluble Receptor for Advanced Glycation End-Products Inhibits Hypoxia/Reoxygenation-Induced Apoptosis in Rat Cardiomyocytes via the Mitochondrial Pathway
by: Buxing Chen, et al.
Published: (2012-09-01)

Carnitine Inborn Errors of Metabolism
by: Mohammed Almannai, et al.
Published: (2019-09-01)

High BAL sRAGE is Associated with Low Serum Eosinophils and IgE in Children with Asthma
by: Jason T. Patregnani, et al.
Published: (2020-08-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)